Wall Street’s main indexes bounced back on Wednesday after a technology-led selloff in the previous session, as US government bond yields eased from multi-decade highs and investors digested a series of corporate updates, Reuters reported.
Moderna shares more than doubled after a late-stage trial showed that its personalised mRNA cancer therapy, developed with Merck, lowered the risk of melanoma recurrence and spread. Merck climbed 9.6%, boosting the blue-chip Dow.
